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Abstract A chronic elevation of circulating free fatty
acids (FFAs) is associated with diseases like obesity or
diabetes and can lead to lipotoxicity. The goals of this
study were to assess the influence of chronic exposure to
high palmitic acid (PAL) levels on mitochondrial respi-
ratory functions in endothelial cells and isolated mito-
chondria. Human umbilical vein endothelial cells
(EA.hy926 line) were grown for 6 days in a medium
containing either 100 or 150 μM PAL. Growth at high
PAL concentrations induced a considerable increase in
fatty acid-supplied respiration and a reduction of mito-
chondrial respiration during carbohydrate and glutamine
oxidation. High PAL levels elevated intracellular and mi-
tochondrial superoxide generation; increased inflamma-
tion marker, acyl-coenzyme A (CoA) dehydrogenase,
uncoupling protein 2 (UCP2), and superoxide dismutase
2 expression; and decreased hexokinase I and pyruvate
dehydrogenase expression. No change in aerobic respira-
tion capacity was observed, while fermentation was de-
creased. In mitochondria isolated from high PAL-treated
cells, an increase in the oxidation of palmitoylcarnitine, a
decrease in the oxidation of pyruvate, and an increase in
UCP2 activity were observed. Our results demonstrate
that exposure to high PAL levels induces a shift in en-
dothelial aerobic metabolism toward the oxidation of fat-
ty acids. Increased levels of PAL caused impairment and
uncoupling of the mitochondrial oxidative phosphoryla-
tion system. Our data indicate that FFAs significantly
affect endothelial oxidative metabolism, reactive oxygen
species (ROS) formation, and cell viability and, thus,
might contribute to endothelial and vascular dysfunction.
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Introduction
Lining the inner lumen of blood vessels, the endothelium
constitutes the interface between blood and the vessel
wall, which is important in vascular homeostasis.
Endothelial cells play a key role in sensing and
responding to various physiological blood components,
but they are also challenged by pathological stimuli,
which may exert harmful effects on the vascular system
via the excessive formation of reactive oxygen species
(ROS). Endothelial cells are the first target for elevated
levels of lipid-derived free fatty acids (FFAs) in the plas-
ma, one of multiple risk factors of endothelial dysfunc-
tion [16, 24]. Abnormally enhanced levels of circulating
FFAs are observed in type 2 diabetes and obesity that,
together with insulin resistance and inflammation, facili-
tates fat accumulation [1]. Insulin resistance and the local
biosynthesis of tumor necrosis factor alpha (TNFα) pro-
mote lipolysis in the adipose tissue, which stimulates the
release of an additional pool of FFAs that may become
preferential substrates for mitochondrial oxidation. Thus,
metabolic diseases can cause a mismatch between lipid
supply and uptake in adipose tissue, leading to increasing
levels of FFAs, triglycerides, and cholesterol in the blood
plasma [10]. Because endothelial cells are not able to
store large amounts of lipids, pathologically elevated
blood lipid levels are a dangerous metabolic challenge
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for endothelial mitochondria, which threatens their func-
tion and integrity. Because damage to endothelial cells is
an important event in the pathogenesis of atherosclerosis
and vascular disease [16, 24], the apoptotic effects of
FFAs on human endothelial cells could result in serious
health consequences [19]. Moreover, FFAs are important
modulators of the cellular production of ROS [21]. They
can cause oxidative stress and alternations in mitochon-
drial structure and function [20].
Emerging experimental evidence suggests an important
role for endothelial mitochondria in the development of many
cardiovascular diseases [5, 23, 25, 27]. Endothelial mitochon-
dria may function as sensors of changes in the local environ-
ment (in particular, changes in the composition of the perfus-
ate), contributing to the survival of endothelial cells under
oxidative stress. On exposure to cardiovascular risk factors,
endothelial mitochondria produce excessive ROS, which are
important signaling molecules in vascular endothelial cells
[29].
Fatty acids are important sources of energy because, when
metabolized, they yield large quantities of ATP. Endothelial
cells mainly use anaerobically metabolized glucose to
generate ATP [9]. However, primarily glycolytic endothelial
cells possess highly active mitochondria, with a functioning
energy-dissipating system (uncoupling protein 2, UCP2) [14].
UCP2 is a regulator of mitochondrial ROS generation and can
antagonize oxidative stress-induced modifications of endothe-
lial mitochondrial function [23]. It has been shown that high
glucose exposure induces a shift in endothelial aerobic metab-
olism toward the oxidation of lipid-derived FFAs [14].
Many questions must be addressed with respect to
understanding the physiological role that mitochondria
plays in endothelial cells and the contribution of endo-
thelial mitochondria to vascular function and disease.
Hyperlipidemia represents a major risk factor for the de-
velopment of vascular dysfunction and atherosclerosis.
The unfortunate contribution of triglyceride-derived
FFAs to vascular disorders is not completely understood.
Thus, the aim of the present study was to elucidate the
effects of a chronic 6-day exposure to high palmitic acid
(PAL) concentrations on cultured human endothelial
EA.hy926 cells. Cell viability and proliferation and su-
peroxide formation and mitochondrial respiratory func-
tion, including the respiratory response to different re-
ducing fuels and mitochondrial oxidative capacity, were
monitored in cells treated with 100 μM or 150 μM PAL.
Moreover, we examined the effect of the chronic expo-
sure of growing endothelial cells to high PAL concentra-
tions on mitochondria by measuring their respiratory ac-
tivities in phosphorylating and non-phosphorylating
states, the yield of ATP synthesis, mitochondrial mem-
brane potential (mΔΨ), and mitochondrial protein-
mediated uncoupling.
Material and methods
Cell culture and cell fraction preparation
We used the stable human endothelial cell line EA.hy926
(ATCC® CRL-2922™), which was originally derived from
a human umbilical vein [7]. Cells were grown in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 10 %
fetal bovine serum (FBS), 1 % L-glutamine, 2 %
hypoxanthine-aminopterin-thymidine (HAT), and 1 %
penicillin/streptomycin in a humidified 5 % CO2 atmosphere
at 37 °C. Except for the determinations of the time course and
dose-dependency of the intercellular adhesion molecule 1
(ICAM1) expression level (Fig. 1), the EA.hy926 cells were
cultured for 6 days in DMEM culture in the absence (FFA-free
control conditions) or presence of 100 or 150 μM PAL
(representing high FFA conditions). In the FFA-treated cells,
albumin-conjugated FFAs (i.e., 100 or 150 μM PAL at ratios
of fatty acid to albumin of 2.4:1 and 3.6:1, respectively) were
added to the culture medium at the inoculation step. PAL
makes up a major fraction of the saturated FFAs in the plasma.
Cell culture media were changed every 3 days throughout the
culturing period. The EA.hy926 cells were cultured in 140-
mm dishes until they reached approximately 90–100 % con-
fluence. Cells that were used in this study were between pas-
sages 5 and 12.
EA.hy926 cell cultures from both the control and high PAL
cultures were harvested with trypsin/EDTA, rinsed twice with
phosphate-buffered saline (PBS) (containing 10 and 5 % FBS,
respectively), and centrifuged at 1200×g for 10 min.
Subsequently, the cells were washed in cold PBS medium
and then centrifuged again. The final cell pellet was resus-
pended in the PBS medium (1 g of cells per 2 ml of medium)
and kept on ice. Protein content was determined using the
Bradford method (Bio-Rad). The yield of the harvested cells
differed significantly between the control and the 100 and
150 μM PAL-treated cells. Namely, 4.3 ± 0.4, 2.5 ± 0.17,
and 0.6 ± 0.05 g of cells (SD, n = 12), respectively, were
harvested from 50 dishes of each culture (when all types of
cells were inoculated at the same density).
Measurements of cell respiration
The detached untreated and PAL-treated (100 or 150 μMPAL)
EA.hy926 cells were resuspended in cold DMEJ ion medi-
um (modified DMEM medium), instead of PBS medium,
containing 5.4 mM KCl, 0.8 mM MgSO4, 110 mM NaCl,
44mMNaHCO3, 1.1 mMNaH2PO4, and 10mMNa/Na buffer
(pH 7.5). Cellular oxygen uptake was measured at 37 °C using
a Clark-type electrode (Hansatech) in 0.7 ml of DMEJmedium.
The mitochondrial function in detached EA.hy926 cells
was determined polarographically as previously described
[14]. The following respiratory substrates were used: 5 mM
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pyruvate, 5.5 mM glucose, 3 mM glutamine, or 0.3 mM PAL.
To estimate the contribution of ATP-linked oxygen consump-
tion rate (OCR) and non-ATP-linked OCR (proton leak) to the
basal respiratory rate, oligomycin (1 μg/ml) was added to
inhibit ATP synthesis. Subsequently, the proton ionophore
(uncoupler) carbonyl cyanide 4-(trifluoromethoxy)
phenylhydrazone (FCCP, 0.5 μM) was added to determine
the maximal oxygen uptake that the cells could sustain.
Finally, cyanide (0.5 mM) was added to inhibit Complex IV
(cytochrome c oxidase, COX) and thereby block the entire
mitochondrial cytochrome pathway. In the presence of cya-
nide, no residual (non-mitochondrial) respiration was
observed.
Mitochondrial isolation and cytosolic fraction preparation
Mitochondria were isolated from EA.hy926 cells using a very
efficient isolation procedure that produces highly active and
well-coupled mitochondria [14]. After the cells were harvest-
ed and washed in PBS, cells were resuspended in PREPI me-
dium (0.25 M sucrose, 1.5 mM EDTA, 1.5 mM EGTA, 0.2 %
BSA, and 15 mM Tris/HCl, (pH 7.2)) at a ratio of 3 ml of
medium per 1 g of cells. The cells were then homogenized via
ten passes with a tight Dounce homogenizer, and the homog-
enates were subsequently centrifuged at 1200×g for 10 min.
The pellets were resuspended, and the cells were once again
homogenized (10–8 passes) and centrifuged to collect the mi-
tochondria remaining in the pellet. The supernatants were
combined and then centrifuged at 1200×g for 10 min, and
the resulting supernatants were then centrifuged at 12,000×g
for 10 min. The mitochondrial pellets were washed with a
PREPII medium containing 0.25 M sucrose and 15 mM
Tris/HCl (pH 7.2) and centrifuged at 12,000×g for 10 min.
All of the steps were performed at 4 °C. The final mitochon-
drial pellet was resuspended in the PREPII medium. The
yields of the isolated mitochondria were equal to 3.3 ± 0.6,
2.8 ± 0.5, and 1.33 ± 0.3 mg ofmitochondrial protein per gram
of cells (SD, n = 10) for cells grown under control conditions
and in the presence of 100 or 150 μM PAL, respectively.
To obtain cytosolic fractions for enzymatic measurements,
cells were homogenized in one step in the PREPII medium
with the Dounce homogenizer (30 passes). The homogenates
were subsequently centrifuged at 1200×g for 10 min. After
spinning down the unbroken cells and cell debris, the super-
natants were collected for measurements of citrate synthase
(CS) activity and COX activity.
Measurements of mitochondrial respiration
and membrane potential
Mitochondrial respiration and membrane potential (mΔΨ)
were measured in isolated endothelial mitochondria as
Fig. 1 PAL-induced impairment
of endothelial EA.hy926 cells. a
Dose- and time-dependent levels
of ICAM1 protein expression in
control (C) and PAL-treated
(PAL) endothelial EA.hy926 cells.
PAL-treated cells were cultured
for 12, 24, and 48 h or for 6 days
with 100–400 μM PAL.
Examples of immunoblots are
shown. The same amount of
proteins (40 μg) were loaded into
each lane. Viability (b) and
density (c) of cells in culture
dishes after chronic exposure (the
6-day exposure) to 100 μM PAL
(100 PAL) or 150 μM PAL (150
PAL). b, c Results are presented
as the means ± SD; n = 7. p < 0.05
(#), p < 0.01 (**), or p < 0.001
(*** or ###). Asterisks (**, ***)
are comparison vs. control values.
Number signs (#, ###) are
comparison between values
obtained for cells grown in the
presence of 100 μM PAL and
those grown in the presence of
150 μM PAL
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previously described [14]. Oxygen uptake was determined
polarographically using a Rank Bros. (Cambridge UK) oxy-
gen electrode or a Hansatech oxygen electrode in either 1.4 or
2.8 ml of standard incubation medium (at 37 °C), which
consisted of 150 mM sucrose, 2.5 mM KH2PO4, 2 mM
MgCl2, 20 mM Tris/HCl (pH 7.2), and ±0.1 % BSA, with
either 0.7 or 2 mg of mitochondrial protein. O2 uptake values
are presented in nmol O2 min
−1 mg−1 protein. Membrane po-
tential was measured simultaneously with oxygen uptake
using a tetraphenylphosphonium (TPP+)-specific electrode.
The TPP+-electrode was calibrated based on four sequential
additions (0.4, 0.4, 0.8, and 1.6 μM) of TPP+. After each run,
0.5 μM FCCP was added to release the TPP+ for a baseline
correction. To calculate the mΔΨ value, the matrix volume of
endothelial mitochondria was assumed to be 2.0 μl mg−1 pro-
tein. The calculation assumed that the TPP+ distribution be-
tween the mitochondria and the medium followed the Nernst
equation. The mΔΨ values were corrected for TPP+ binding
using the apparent external and internal partition coefficients
of TPP+ [28]. This correction decreased the calculated mΔΨ
values (approx. 30-mV shift), but it did not influence the
changes in the resulting membrane potential (relative chang-
es). The values for mΔΨ are given in millivolts.
Phosphorylating respiration was measured using 150 μM
ADP (pulse), and uncoupled respiration was measured using
up to 0.5 μM FCCP. Only high-quality mitochondria prepara-
tions, i.e., with an ADP/O value of approximately 2.2 and a
respiratory control ratio of approximately 2.6–3.2 (with ma-
late as a respiratory substrate), were used in the experiments.
Non-phosphorylating (resting state) respiration measurements
were performed in the absence of exogenous ADP.
The proton leak measurements were performed with
10 mM succinate (plus 2 μM rotenone) as an oxidizable sub-
strate, in the presence of 1.8 μM carboxyatractyloside and
0.5 μg/ml oligomycin, which inhibit the activities of the
ATP/ADP antiporter and ATP synthase, respectively. The re-
sponse of proton conductance to its driving force can be
expressed as the relationship between the oxygen consump-
tion rate and the mΔΨ (flux-force relationship) when varying
the potential via titration with respiratory chain inhibitors. To
decrease the rate of the coenzyme Q-reducing pathway, suc-
cinate dehydrogenase was titrated with malonate (up to
4 mM). To induce UCP2 activity, 14 μM PAL was used. To
inhibit UCP2 activity, 4 mM guanosine triphosphate (GTP)
was applied.
Measurement of enzyme activities
The activity of CS was determined by spectrophotometrically
tracking the formation of DTNB-CoA at 412 nm using a UV
1620 Shimadzu spectrophotometer as described previously
[14, 32]. The reaction mixture contained 100 mM Tris/HCl
(pH 8.0) 100 μM acetyl CoA, 100 μM 5,5′-di-thiobis-(2-
nitrobenzoic acid) (TNB), 0.1 % Triton X-100, and 100 μM
oxaloacetate. The activity of lactate dehydrogenase (LDH)
was measured spectrophotometrically at 340 nm by following
the oxidation of NADH (150 μM) mixed with pyruvate
(10 mM) in 50 mM Tris/HCl (pH 7.3) [15]. The activity of
both enzymes was measured in 50 μg of protein from the
cytosolic fractions obtained from living endothelial cells.
The maximal activity of COX and the integrity of the outer
mitochondrial membrane were assessed polarographically as
described previously [14]. The maximal activity of COX was
assessed in 2 mg of cellular protein or in 0.25 mg of mito-
chondrial protein without exogenously added respiratory sub-
strate and in the presence of sequentially added antimycin A
(10 μM), 8 mM ascorbate, 0.06 % cytochrome c, and up to
2 mM N,N,N′N′-tetramethyl-p-phenylenediamine (TMPD).
The rate of oxygen consumption following the addition of
TMPD reflects the maximal O2 consumption by COX
(Complex IV). The integrity of the outer mitochondrial mem-
brane was assayed in mitochondrial fractions as the latency of
COX activity during the oxygen uptake measurements in the
absence and presence of exogenous cytochrome c.
All enzymatic measurements were performed at 37 °Cwith
continuous stirring.
Determination of superoxide anion formation in cells
ROS production was detected using a nitroblue tetrazolium
(NBT) assay with untreated and PAL-treated EA.hy926 cells.
NBT (yellow water soluble) was reduced by superoxide to
formazan-NBT (dark-blue water insoluble). The assay was
performed by incubating detached cells (0.2 mg of protein in
a 1-ml DMEM) or adherent cells (grown in dishes) with 0.2 %
NBT under agitation. The samples were incubated for 1 h
(37 °C) in the p re sence o r absence o f 10 μM
diphenyleneiodonium (DPI) (an inhibitor of NADPH oxidase
and endothelial nitric oxide synthase (eNOS), enzymes in-
volved in endothelial ROS formation), and the adherent cells
were harvested. The cells were centrifuged (1200×g for
10 min at 4 °C), the supernatant was removed, and the
formazan-NBT was dissolved in 200 μl of 50 % acetic acid
by sonication (three pulses of 10 s each; Bandelin Electronic).
The samples were briefly centrifuged (spun down), and the
absorbance of the supernatant was determined at 560 nm
using a UV 1620 Shimadzu spectrophotometer.
Additionally, mitochondrial superoxide formation was
measured using MitoSox Red (Invitrogen), a specific fluores-
cent mitochondrial superoxide indicator. The assay was per-
formed by incubating detached cells (50 μg of protein in 1 ml
medium) or adherent cells (grown in 96-well plates) with
5 μM MitoSox in PBS containing 5.5 mM D-glucose and
5 mM pyruvate for 10 min at 37 °C. Cells were washed twice
with PBS. Fluorescence emission at 595 nm under 510-nm
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excitation was recorded using an Infinite M200 PRO Tecan
multimode reader.
Measurement of mΔΨ in cells
To measure mΔΨ of the control and PAL-treated EA.hy926
cells, JC-1 (Invitrogen), a mΔΨ indicator in living cells, was
used. The assay was performed by incubating detached cells
(50 μg of protein in 1-ml medium) with 2 μM JC-1 in PBS
containing 5.5 mM D-glucose and 5 mM pyruvate for 10 min
at 37 °C. After incubation, cells were washed five times with
PBS. Red aggregate fluorescence emission at 590 nm under
535-nm excitation was recorded using an Infinite M200 PRO
Tecan multimode reader in 96-well plates (5 μg of cell protein
per well). Measurements were performed in the absence and
presence of 0.04 μM FCCP (a protonophore) to confirm that
directional changes in fluorescence can be attributed to mito-
chondrial mΔΨ. For control and PAL-treated cells, FCCP-
sensitive changes in fluorescence were calculated.
Trypan blue cell viability assay
Both living and dead cells were harvested from cultures. After
cell harvesting, 0.4 % trypan blue solution was added (1:1
v/v), and cell viability was determined using a Countess
Automated Cell Counter (Invitrogen). In a trypan blue exclu-
sion assay, cells that take up the dye are either necrotic or
apoptotic.
Determination of protein levels via immunoblotting
RIPA buffer (150 mM NaCl, 1 % Triton X-100, 0.5 % Na
deoxycholate, 0.1 % SDS, 50 mM Tris (pH 8.0)) was used
to lyse endothelial cells. The cellular and mitochondrial frac-
tions were isolated in the presence of protease inhibitors
(Sigma). The proteins were separated on an 8–12 % SDS-
PAGE gel. The Spectra™ Multicolor Broad Range Protein
Ladder (Fermentas) was used as a molecular weight marker.
The following primary antibodies were used: rabbit monoclo-
nal anti-intercellular adhesion molecule 1 (ICAM1, 89 kDa)
(an53013, Abcam), mouse monoclonal anti-β actin (42 kDa)
(CP01, Calbiochem), mouse monoclonal anti-hexokinase I
(HKI, 120 kDa) (sc-80978, Santa Cruz Biotechnology), rabbit
monoclonal anti-acyl-coenzyme A dehydrogenase (ACADS,
44 kDa) (ab-154823, Abcam), mouse monoclonal lactate de-
hydrogenase (LDH, 35 kDa) (sc-133123, Santa Cruz
Biotechnology), rabbit polyclonal glutamate dehydrogenase
(GDh, 61 kDa) (ab89967, Abcam), purified goat polyclonal
anti-E3-binding protein of pyruvate dehydrogenase (E3BP,
54 kDa) (sc-79236, Santa Cruz Biotechnology), rabbit poly-
clonal anti-UCP2 (33 kDa) (ab97931, Abcam), rabbit poly-
clonal anti-UCP3 (34 kDa) (ab3477, Abcam), rabbit mono-
clonal antimitochondrial superoxide dismutase 2 (SOD2,
25 kDa) (ADI-SOD-110, Enzo Life Sciences), rabbit poly-
clonal anticitrate synthase (CS, 52 kDa) (ab-96600, Abcam),
mouse monoclonal antimitochondrial marker (MTC02,
60 kDa), and the MitoProfile® total OXPHOS human anti-
body cocktail (MS601, MitoScience) containing antibodies
raised against subunits of Complex I (20 kDa subunit
NDUFB8), Complex II (30 kDa subunit), Complex III (sub-
unit Core 2, 47 kDa), Complex IV (COXII, 24 kDa), and ATP
synthase (subunit α, 57 kDa). Appropriate horseradish
peroxidase-conjugated secondary antibodies were used. The
expression levels of COXII or a mitochondrial marker (for the
mitochondrial fractions) and of β-actin (for the cell fractions)
were used as loading controls for normalization. Protein bands
were visualized using the Amersham ECL system and digital-
ly quantified using the GeneTools 4.03 software package.
Statistical analysis
Data are presented as the means ± SD obtained from at least
five to ten independent experiments (cell suspension prepara-
tions or mitochondrial isolations), and each determination was
performed at least in duplicate in this study. Significant differ-
ences were determined via unpaired t tests or ANOVAs
(followed by Tukey’s post hoc comparisons for P < 0.05 from
an ANOVA). Differences were considered to be statistically
significant at p < 0.05 (* or #), p < 0.01 (** or ##), or p < 0.001
(*** or ###). Asterisks (*, **, ***) represent comparisons of
data obtained between PAL-treated cells and untreated control
cells. Number signs (#, ##, ###) represent comparisons be-
tween PAL-treated cells, i.e., cells grown in the presence of
100 μM PAL compared to cells grown in the presence of
150 μM PAL.
Results
Time course and dose response of PAL-induced
inflammatory marker and cytotoxicity in cultured
endothelial EA.hy926 cells
To determine the time course and dose-dependency of the
inflammatory response induced by elevated PAL levels, we
measured ICAM1 protein expression levels in EA.hy926 cells
after different exposure times with 100–400 μMPAL (Fig. 1).
The results indicate that the inflammatory increases with the
duration of exposure and with increasing concentrations of
FFA. The most pronounced inflammatory response was found
after the 6-day exposure with 400 μM PAL. However, this
high-dose, long-term treatment led to an enormous decrease
in cell viability that prevented bioenergetic studies. Therefore,
to further study the effect of elevated PAL levels on endothe-
lial cells after a chronic 6-day exposure, we used PAL con-
centrations of 100 and 150 μM. Under these conditions, the
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ICAM1 expression level was significantly elevated (Figs. 1a
and 2a). In addition to the increased ICAM1 expression, treat-
ment with PAL resulted in a dose-dependent decrease in cell
viability and density (Fig. 1), indicating the induction of cell
death and a reduction of cell proliferation in PAL-treated en-
dothelial EA.hy926 cells.
In endothelial cells, growth in the presence of high PAL
concentrations caused increased fatty acid-supplied
respiration and reduced mitochondrial respiration
during carbohydrate and glutamine oxidation
To examine how EA.hy926 cells grown under control or high
PAL (100 or 150μM) conditions respond to simple changes in
respiratory substrates, mitochondrial respiratory function (ox-
ygen uptake) was measured. Under basal conditions (basal
OCR) (Fig. 3a), FCCP-stimulated conditions (maximal
OCR) (Fig. 3b) and in the presence of oligomycin
(oligomycin-resistant, ATP-linked OCR) (Fig. 3d), all cells,
independent of PAL exposure level during culturing, demon-
strated the highest OCR with pyruvate or glutamine and the
lowest OCR with PAL as the respiratory substrate. Among the
tested OCRs, the non-ATP-linked OCR (proton leak) exhibit-
ed the least dependence on the type of reducing substrate
present (Fig. 3c).
In general, under all respiratory conditions and with respect
to all reducing fuels except PAL, the EA.hy926 cells grown at
a higher concentration of PAL (150 μM) displayed a
Fig. 2 Determination of protein
levels in endothelial cells grown
for 6 days in the presence of
100 μMPAL (100 PAL), 150 μM
PAL (150 PAL), or under control
(C) conditions (a) and in
mitochondria isolated from these
cells (b). a Representative
Western blots and analyses of the
protein expression of ICAM1,
cytochrome c oxidase (COXII),
lactate dehydrogenase (LDH),
hexokinase I (HKI), citrate
synthase (CS), and mitochondrial
marker (Mito marker). b
Representative Western blots and
analyses of the protein expression
of the uncoupling proteins UCP2






citrate synthase (CS) (upper
panel) and particular subunits of
ATP synthase, Complex III (CIII),
Complex II (CII), Complex IV
(CIV, COXII), and Complex I
(CI). Expression levels
normalized for β actin (a), Mito
marker (b, upper panel) or COXII
(b, lower panel) protein
abundance is shown. Results are
presented as the means ± SD;
n = 8. p < 0.05 (*), p < 0.01 (** or
##), or p < 0.001 (*** or ###).
Asterisks (*, **, ***) are
comparison vs. control values (C,
no PAL). Number signs (##, ###)
are comparison between values
obtained for cells grown in the
presence of 100 μM PAL and
those grown in the presence of
150 μM PAL
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significantly reduced mitochondrial function relative to the
cells exposed to control conditions or to 100 μM PAL
(Fig. 3). In particular, cells treated with 150 μM PAL exhibit-
ed 1.5- to 1.9-fold reductions in their maximal mitochondrial
respiratory capacity in the presence of pyruvate, glucose, or
glutamine (Fig. 3b). Similarly, with these substrates, a signif-
icantly reduced ATP-linked OCR was observed in 150 μM
PAL-treated cells, indicating diminished levels of mitochon-
drial oxidative phosphorylation during carbohydrate and ami-
no acid catabolism (Fig. 3d). Interestingly, in the case of glu-
cose, a decrease in maximal respiratory capacity and basal
respiration was found in both types of high PAL-treated cells.
For cells grown in the presence of 100 μMPAL, no significant
changes in maximal respiration or ATP-linked respiration
were observed with pyruvate or glutamine when compared
with rates in the control cells. Thus, mitochondrial respiratory
measurements indicate a reduction in mitochondrial respira-
tion during carbohydrate and glutamine oxidation in high
PAL-treated endothelial cells, especially in those treated with
150 μM PAL.
In contrast, the oxidation of PAL was significantly
higher in both of the high PAL-treated cell groups (100
and 150 μM) (Fig. 3b, d). These results indicate that
there is a greater contribution from fatty acids as a fuel
source for endothelial respiration during growth at high
PAL concentrations.
Interestingly, an increase in the non-ATP-linked OCR (pro-
ton leak) in the presence of all reducing fuels, including PAL,
was observed in cells treated with 100 μM PAL but not in
those treated with 150 μM PAL (Fig. 3c). Thus, an elevated
uncoupling of respiration was not found in 150 μM PAL-
treated cells, whereas a general reduction of aerobic metabo-
lism was observed in these cells, except in the case of FFA
oxidation.
In endothelial cells, growth in the presence of high PAL
concentrations did not change mitochondrial biogenesis
or aerobic respiration capacity but did reduce
fermentation
The endothelial cells cultured in the control conditions or high
PAL conditions (both at 100 or 150 μM PAL) exhibited sim-
ilar CS and COX activities (Fig. 4a, b), indicating that the
different growth conditions did not change the capacities of
the tricarboxylic acid (TCA) cycle or the mitochondrial respi-
ratory chain. Moreover, no differences in the expressions of
mitochondrial markers COXII and CS were detected in the
control and PAL-treated cells (Fig. 2a). These results indicate
Fig. 3 Oxidative metabolism (respiration) of EA.hy926 cells grown for
6 days in the presence of 100 μM PAL (100 PAL), 150 μM PAL (150
PAL), or under control conditions (no PAL). Substrate-dependent
changes in the basal oxygen consumption rate (a), maximal oxygen
uptake (b), proton leak (c), and ATP-dependent oxygen uptake (d).
Substrates: 5 mM pyruvate, 5.5 mM glucose, 3 mM L-glutamine, or
0.3 mM PAL. Results are presented as the means ± SD; n = 7. p < 0.05
(* or #), p < 0.01 (** or ##), or p < 0.001 (*** or ###). Asterisks (*, **,
***) are comparison vs. control values (no PAL). Number signs (#, ##,
###) are comparison between values obtained for cells grown in the
presence of 100 μM PAL and those grown in the presence of 150 μM
PAL
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that growing in the presence of high PAL concentrations does
not change the mitochondrial biogenesis (mitochondrial con-
tent) or the cell’s capacity for aerobic respiration.
However, in cells grown at high PAL concentrations, a
slight but statistically significant reduction in the activity of
LDH, the enzyme that catalyzes the interconversion of pyru-
vate and lactate, was observed (∼10 and ∼20 % decrease in
cells from 100 and 150 μM PAL cultures, respectively)
(Fig. 4c). The changes in activity were accompanied by a
slight downregulation of LDH at the protein level (Fig. 2a).
Moreover, a decrease in the expression of HKI, the enzyme
catalyzing the first step of the glycolytic pathway, which is the
rate-limiting step, was found in both types of high PAL-treated
cells (Fig. 2a). Thus, these results indicate that cells grown at
high PAL concentrations display a diminished anaerobic glu-
cose oxidation via the glycolytic pathway and lactic acid
fermentation.
In endothelial cells, growth at high PAL concentrations
increased mitochondrial and non-mitochondrial
superoxide generation, and the increase was less
pronounced in cells treated with 150 μM PAL
As shown in Fig. 5a, b, compared with the cells cultured under
control conditions, the exposure of EA.hy926 cells to high
PAL concentrations, both 100 and 150 μM PAL, caused a
significant elevation in total and mitochondrial superoxide
generation. Mitochondrial superoxide generation was mea-
sured either as DPI-insensitive NBT reduction (Fig. 5a) or
MitoSOX oxidation (Fig. 5b). A significantly less-
pronounced increase in total and mitochondrial superoxide
formation was found in cells treated with 150 μM PAL (∼37
and ∼22 % increase, respectively) compared to those treated
with 100 μM PAL (∼70 and ∼50 % increase, respectively).
We found that in both types of PAL-treated cells, DPI, a fla-
voprotein inhibitor of NADPH oxidase and eNOS, signifi-
cantly inhibited (∼30 % reduction) PAL-induced superoxide
generation (Fig. 5a). Therefore, in EA.hy926 cells, high PAL-
induced ROS production appears to occur via enzyme sources
and mitochondrial sources (including DPI-insensitive
sources). High PAL-induced mitochondrial and non-
mitochondrial ROS production changes were both less pro-
nounced in cells treated with 150 μM PAL than in those treat-
ed with 100 μM PAL.
Significant changes in mΔΨ were observed, i.e., ∼60 %
increase and ∼30 % decrease, in cells treated with 100 or
150 μM PAL, respectively (Fig. 5c).
Increased levels of PAL resulting from the growth of cells
at high PAL concentrations caused impairment
and uncoupling of the mitochondrial oxidative
phosphorylation system
To determine the effect of cell growth at high PAL concentra-
tions on respiratory activity at the mitochondrial level, we
measured the oxidation of reducing substrates in isolated en-
dothelial mitochondria. Figure 6a shows the maximal mito-
chondrial respiration rates (phosphorylating or uncoupled res-
piration) with different respiratory substrates in mitochondria
isolated from high PAL-treated and control cells. The highest
maximal mitochondrial respiration rate was observed with
malate or succinate, substrates which saturate the capacity of
the endothelial respiratory chain [14]. Glutamate (an interme-
diate of amino acid metabolism), glycerol-3-phosphate, and
palmitoylcarnitine (lipid breakdown intermediates) were more
weakly oxidized by EA.hy926 mitochondria than were malate
or succinate (TCA cycle intermediates) (Fig. 6a). Moreover,
the oxidation of pyruvate was not as intense as the oxidation
of these two TCA cycle intermediates. In mitochondria isolat-
ed from cells grown at high PAL concentrations, the oxidation
of glutamate and glycerol-3-phosphate remained unchanged.
However, the oxidation of pyruvate was significantly reduced
by ∼32 % but only in mitochondria from cells treated with
150 μM PAL. This change was accompanied by a
Fig. 4 Maximal activities of marker enzymes of aerobic (a, b) and
anaerobic catabolism (c) in EA.hy926 cells grown for 6 days in the
presence of 100 μM PAL (100 PAL), 150 μM PAL (150 PAL), or
under control conditions (no PAL). Enzymes analyzed include citrate
synthase (CS) (a), cytochrome c oxidase (COX) (b), and lactate
dehydrogenase (LDH) (c). Results are presented as the means ± SD;
n = 7. p < 0.05 (asterisk), comparison vs. control values (no PAL)
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downregulation of the E3BP component of pyruvate dehydro-
genase (Fig. 2b). Similarly, a higher concentration of PAL in
the growth cultures resulted in a decrease in mitochondrial
malate and succinate oxidation (Fig. 6a).
Growth under high PAL concentrations did not influ-
ence the expression of components of the oxidative phos-
phorylation system in EA.hy926 mitochondria (Fig. 2b).
The expression levels of subunits for ATP synthase (α)
and the four respiratory chain complexes, namely,
Complex I (NDUFB8), Complex II (subunit 30 kDa),
Complex III (Core2), and Complex IV (COXII), were
not affected. In addition, no change in the expression lev-
el of CS or glutamate dehydrogenase was observed
(Fig. 2b). Moreover, the maximal COX activity was also
unaffected (Fig. 6b).
The comparison of mitochondrial respiratory activity, cou-
pling parameters (Table 1), and mΔΨ (Fig. 6c) in the absence
and presence of 0.1 % BSA, acting as an FFA chelator, indi-
cates that increased levels of PAL resulting from the growth of
cells at high PAL concentrations could cause impairment and
uncoupling of the mitochondrial oxidative phosphorylation
system. In the absence of BSA, (i) a significant decrease in
phosphorylating (state 3) respiration, indicating an inhibition
of respiratory chain, and (ii) a significant decrease in the ADP/
O ratio and respiratory control ratio together with a significant
increase in non-phosphorylating respiration, indicating mito-
chondrial uncoupling, were observed during malate oxidation
in mitochondria isolated from cells exposed to high PAL con-
centrations (Table 1). The highest reduction in phosphorylat-
ing respiration and the greatest extent of mitochondrial
uncoupling in the absence of BSAwere observed inmitochon-
dria from cells treated with 150 μM PAL. In the presence of
BSA, these effects were found only for mitochondria isolated
from cells treated with 150 μM PAL. Moreover, in non-
phosphorylating and phosphorylating malate-oxidizing mito-
chondria, the mΔΨ was significantly diminished in the ab-
sence of BSA, especially in mitochondria from 150 μM PAL-
treated cells (by ∼7 and ∼5 mV, respectively) (Fig. 6c).
Changes in mΔΨ (Fig. 6c) reflect changes in respiratory rates
(Table 1). In the absence of BSA, in non-phosphorylating
mitochondria, the decrease in mΔΨ (Fig. 6c) was accompa-
nied by an increase in respiratory rate (Table 1) indicating
increased mitochondrial uncoupling. In phosphorylating mi-
tochondria, the decrease in mΔΨ (Fig. 6c) was accompanied
by a decrease in respiratory rate (Table 1), indicating inhibi-
tion of mitochondrial respiratory chain. In the presence of
BSA, simultaneous changes in mΔΨ (a decrease) and respi-
ratory rate (an increase) were only observed for non-
phosphorylating mitochondria from cells grown at the higher
PAL concentration. It seems that 0.1 % BSAwas able to che-
late excess FFAs only in mitochondria from cells treated with
100 μM PAL. Moreover, mitochondria isolated from cells
treated with 150 μM PAL exhibited a slight but statistically
significant reduction in the integrity of the outer mitochondrial
membrane (96.04 ± 0.39 %, SD, n = 8) compared to mito-
chondria from control cells (98.01 ± 0.69 %, SD, n = 8) and
those treated with 100 μM PAL (97.11 ± 0.63 %, SD, n = 8).
The above results indicate that increased levels of PAL
resulting from the growth of cells at high PAL concentrations
could cause impairment and uncoupling of the oxidative phos-
phorylation system in endothelial mitochondria.
Fig. 5 Cellular andmitochondrial superoxide formation (a, b) andmΔΨ
(c) in endothelial cells grown for 6 days in the presence of 100 μM PAL
(100 PAL), 150 μM PAL (150 PAL), or under control conditions (no
PAL). a Measurements of superoxide formation with NBT were
performed in the absence or presence of 10 μM DPI. b Measurements
of superoxide formation with theMitoSox probe. Results are presented as
the means ± SD; n = 8. p < 0.05 (*), p < 0.01 (** or ##), or p < 0.001 (***
or ###). Asterisks (*, **, ***) are comparison vs. control values (no
PAL). Number signs (##, ###) are comparison between values obtained
for cells grown in the presence of 100 μM PAL and those grown in the
presence of 150 μM PAL
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Growth under high PAL conditions induced an increase
in the mitochondrial oxidation of palmitoylcarnitine
In contrast to the oxidation of other respiratory sub-
strates, the mitochondrial oxidation of palmitoylcarnitine
was significantly increased by ∼16 and ∼48 % in mito-
chondria isolated from endothelial cells treated with 100
and 150 μM PAL, respectively (Fig. 6a). Moreover, in
EA.hy926 mitochondria, a high PAL level during cell
growth increased (by ∼70 and ∼130 % for mitochondria
from cells treated with 100 and 150 μM PAL, respec-
tively) the expression of acyl-CoA dehydrogenase
(ACADS) (Fig. 2b), which catalyzes the initial step of
fatty acid β-oxidation. These findings are consistent with
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the greater oxidation of PAL that was observed in both
types of the high PAL-treated cells (Fig. 3), indicating a
greater oxidation of reducing substrates originating from
fatty acid β-oxidation.
Growth under high PAL conditions induced increased
UCP2 activity
Using a Western blot analysis, the expression of UCP2 and
UCP3, but not UCP1, could be detected in EA.hy926 cells
[26]. In our study, the analysis of UCP2 protein expression
(Fig. 2b) showed a considerable upregulation of the protein in
mitochondria isolated from high PAL-treated cells relative to
those isolated from untreated control cells. Namely, ∼2.5-fold
and ∼2-fold elevations in UCP2 protein levels were found in
mitochondria from cells treated with 100 and 150 μM PAL,
respectively, relative to the level in the control cells. However,
endothelial cells grown at high PAL concentrations exhibited
UCP3 expression levels in the mitochondria that were similar
to that of the control mitochondria (Fig. 2b). Because it seems
that UCP2 is the only UCP involved in the high-PAL-induced
modifications that occur in EA.hy926 endothelial cells, we
attribute the high PAL-induced changes in UCP activity,
described below, to UCP2.
To determine whether UCP2 activity is changed due to
the growth of EA.hy926 cells with high PAL concentra-
tions, we evaluated the activation of UCP2 by FFAs
(PAL) and the inhibition by GTP in isolated endothelial
m i t o c hond r i a ( F i g . 6 d ) . I n g e n e r a l , i n non -
phosphorylating mitochondria isolated from cells grown
under high PAL conditions, the stimulatory effect of
PAL and the inhibitory effect of GTP were considerably
stronger than the effects observed in the control mito-
chondria. Figure 6d (left panel) shows an example of the
relationship between the oxygen consumption rate and the
mΔΨ (flux-force relationship) during succinate oxidation
titrated with malonate for mitochondria isolated from cells
treated with 100 μM PAL. An analysis of the proton leak
kinetics indicates that for specific PAL (14 μM) and GTP
(2 mM) concentrations, the PAL-induced, GTP-inhibited,
UCP2-mediated proton leak (UCP2 activity) at the same
mΔΨ (156 mV) was ∼2-fold and 1.6-fold higher in mito-
chondria from the cells treated with 100 and 150 μM
PAL, respectively, than it was in the control mitochondria
(Fig. 6d, right panel).
Thus, these results indicate that in response to high PAL
concentrations during endothelial cell growth, UCP2 activity
and protein levels are considerably increased, but the increase
is less pronounced in mitochondria from the cells grown at a
higher PAL concentration (150 μM PAL). Similarly, superox-
ide dismutase 2 (SOD2), another mitochondrial antioxidant
protein was upregulated in both types of high PAL-treated
cells (Fig. 2b).
Table 1 Respiratory rates and coupling parameters in endothelial
mitochondria isolated from cells grown for 6 days in the presence of
100 μM PAL (100 PAL) or 150 μM PAL (150 PAL)
Mitochondria
Control 100 PAL 150 PAL
Malate + BSA
State 4 19.2 ± 2.0 19.3 ± 2.2 25.0 ± 2.4*, #
State 3 71.0 ± 0.6 65.0 ± 0.6 62.5 ± 0.5*
RCR 3.7 ± 0.3 3.6 ± 0.3 2.5 ± 0.3**, ##
ADP/O 2.25 ± 0.20 2.21 ± 0.21 2.20 ± 0.18
Malate − BSA
State 4 21.3 ± 2.0 24.3 ± 2.2* 29.0 ± 2.4***, ##
State 3 72.3 ± 0.5 65.0 ± 0.6 59.5 ± 0.5**, #
RCR 3.4 ± 0.2 2.7 ± 0.3* 2.1 ± 0.1***, ##
ADP/O 2.20 ± 0.22 2.07 ± 0.16* 1.82 ± 0.18**, #
Respiratory rates were measured in the absence (state 4, non-
phosphorylating respiration) or presence (state 3, phosphorylating
respiration) of 150 μM ADP with 10 mM malate. The respiratory rates
(in nmol O2 × min
−1 × mg−1 protein), and respiratory control ratios
(RCR) and ADP/O ratios are presented. Results are presented as the
means ± SD; n = 6. Asterisksmean comparison vs. control mitochondria.
Number signs mean comparison between values obtained for mitochon-
dria from cells grown in the presence of 100μMPAL and those from cells
grown in the presence of 150 μM PAL
*p < 0.05; **p < 0.01; ***p < 0.001; #p < 0.05; ##p < 0.01
Fig. 6 Functional characteristics of endothelial mitochondria isolated
from cells grown for 6 days in the presence of 100 μM PAL (100
PAL), 150 μM PAL (150 PAL), or under control conditions (no PAL).
a The maximal respiration (phosphorylating respiration or uncoupled
respiration) in the presence of the following respiratory substrates:
10 mM malate, 10 mM succinate, 10 mM pyruvate, 10 mM glutamate,
0.3 mM palmitoyl-DL-carnitine, and 3 mM glycerol-3-phosphate
(glycerol-3-P). Measurements were performed in the presence of 0.1 %
BSA. b The COX activity. c mΔΨ during the oxidation of malate in the
absence of oligomycin and carboxyatractyloside during non-
phosphorylating (state 4, st. 4) and phosphorylating (state 3, st. 3)
respiration, with or without 0.1 % BSA. d UCP2 activity. Succinate
(with 2 μM rotenone) was used as oxidizable substrate. The
mitochondria were incubated in the absence or presence of 14 μM PAL
and/or 4 mM GTP. Measurements were performed in the presence of
1.8 μM carboxyatractyloside, 0.5 μg/ml oligomycin, and 0.1 % BSA.
Left: The relationship between the respiratory rate and mΔΨ (proton
leak kinetics) during non-phosphorylating succinate oxidation titrated
with malonate. Results obtained for mitochondria isolated from cells
chronically grown in the presence of 100 μM PAL (100 PAL) are
shown. Right: The PAL-induced, GTP-inhibited, UCP2-mediated
proton leak at the same mΔΨ (156 mV). a–d Results are presented as
the means ± SD; n = 4–8. p < 0.05 (* or #), p < 0.01 (** or ##), or
p < 0.001 (***). Asterisks (*, **, ***) are comparison vs. control
mitochondria. Number signs (#, ##) are comparison between values
obtained for mitochondria isolated from cells grown in the presence of
100 μM PAL and those isolated from cells grown in the presence of
150 μM PAL
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Discussion
Our results show that the treatment of endothelial cells with
high PAL levels resulted in an increase in cell inflammatory
response and a marked decrease in cell viability and density,
indicating the induction of cell death and a reduction of cell
proliferation in PAL-treated EA.hy926 cells. The lipotoxic
effects of high levels of FFAs on endothelial cells have been
described previously. Human brain microvascular endothelial
cells (HBMVECs) exposed to FFAs show significantly de-
creased cell proliferation, increased apoptosis and intracellular
ROS formation, and decreased mΔΨ [31]. In human coronary
artery endothelial cells (hCAEC), exposure to 100 μM PAL
for 24 h has been shown to induce a greater than 2-fold in-
crease in apoptosis [2]. Direct apoptotic effects of FFAs sug-
gest that inappropriate elevations in FFAs may affect vascular
endothelium by impairing cell survival via the activation of
apoptosis, thus contributing to the development of cardiovas-
cular disease in type 2 diabetic patients [19]. Interestingly, in
endothelial EA.hy926 cells, exposure to pathological PAL
concentrations has been shown to induce a lipotoxic response
that finally leads to Ca2+-dependent autophagy and necrotic
cell death [12]. It must be emphasized that in our study, in
which we handle endothelial cell populations that are differ-
ently treated with potentially (at high concentrations) cytotox-
ic PAL, individual experimental readouts might be affected by
dead cells. The results obtained with cells should be therefore
interpreted with caution.
The aim of our study was to determine the effects of
high FFA levels on mitochondrial oxidative metabolism in
endothelial cells, including the effects on isolated endo-
thelial mitochondria. First, we determined how aerobic
metabolism in endothelial EA.hy926 cells supplied with
different reducing fuels was altered by long-term cell
growth in the presence of high PAL concentrations. The
comparison of the mitochondrial respiratory functions of
EA.hy926 cells cultured in the medium with either high
PAL levels or no PAL demonstrate that chronic high PAL
conditions, especially treatment with 150 μM PAL, in-
duce a reduction in mitochondrial respiration supplied
with carbohydrate catabolic intermediates (glucose or py-
ruvate) and glutamine, whereas cellular respiration with
PAL (an intermediate in lipid metabolism) was consider-
ably increased. Moreover, in EA.hy926 mitochondria
from cells grown at high PAL levels, the mitochondrial
oxidation of palmitoylcarnitine and the expression of
acyl-CoA dehydrogenase were significantly increased.
However, in mitochondria from cells treated with
150 μM PAL, the oxidation of pyruvate and the expres-
sion of the E3BP component of pyruvate dehydrogenase
were significantly reduced. Thus, our results show for the
first time that high-PAL conditions lower the contribution
of carbohydrate and amino acid oxidation to the aerobic
metabolism of endothelial cells, whereas the contribution
of FFA oxidation increases. Interestingly, it has been
shown previously that in human umbilical vein endothe-
lial cells (HUVECs), fatty acids can serve as an important
energy source; moreover, the activation of AMP-activated
protein kinase (AMPK), a major factor in modulating the
response of the endothelium to stresses that alter its ener-
gy state, favors the oxidation of FFAs as the source of
ATP production [4].
In EA.hy926 cells grown for 6 days at high PAL concen-
trations, the decreased respiration in the presence of glucose
was accompanied by a reduced expression of hexokinase I and
a decrease in LDH activity. Thus, in addition to a reduction in
aerobic glucose oxidation, endothelial cells grown at high
PAL concentrations seem to also display a diminished anaer-
obic glycolysis. To the best of our knowledge, this is the first
observation of the effect of high PAL levels on glucose catab-
olism in endothelial cells.
It has been well documented that the exposure of endothe-
lial cells to high FFA levels leads to increased intracellular
ROS production and therefore excessive oxidative stress [3,
6, 8, 31]. Under our experimental conditions, the increased
oxidative stress in EA.hy926 cells grown under chronic high
PAL conditions was demonstrated by a significant increase in
intracellular and mitochondrial ROS generation and an upreg-
ulation of the expression of proteins of the mitochondrial an-
tioxidative system, such as SOD2 and UCP2. However, high
PAL-induced mitochondrial ROS production was less pro-
nounced in cells treated with 150 μM PAL than in those treat-
ed with 100 μM PAL, which was likely due to the consider-
able reduction in cell viability in these cells. It seems that at
excessively high PAL levels (150 μM in our study), endothe-
lial cells are no longer able to protect against the overwhelm-
ing oxidative stress, and their antioxidant system is no longer
sufficient.
A surprising reversal of observed effects (i.e., a less pro-
nounced increase or even decrease in observed changes) when
comparing 100 and 150 μM PAL-treated cells to control cells
was found in the (i) expression of mitochondrial antioxidant
proteins UCP2 (and activity) and SOD2, (ii) mitochondrial
ROS formation, and (iii) mΔΨ. Taking all into consideration,
it appears that differences in these parameters are due to dif-
ferences in cell death between 100 and 150 μM PAL-treated
endothelial cells. In 100 μM PAL-treated cells, the increase in
mitochondrial membrane potential, ROS formation, and ex-
pression of antioxidant proteins indicates an important contri-
bution of apoptotic death. In contrast, in 150 μM PAL-treated
cells, a less pronounced increase in mitochondrial ROS for-
mation and expression of antioxidant proteins as well as a
decrease in mΔΨ indicate an increased contribution of necrot-
ic death. This finding is in line with a recent report, in which
PAL-induced necroptosis of endothelial EA.hy926 cells has
been described [12].
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Mitochondria are not only a major intracellular source of
ROS but are also a sensitive target for oxygen radicals.
Mitochondria contribute to cell death by reducing ATP produc-
tion, increasing ROS production, and releasing apoptotic regu-
latory and signaling molecules from the intermembrane space
[17]. Therefore, the high PAL-induced lipotoxicity reflected by
the marked decrease in cell viability of cultured endothelial
EA.hy926 cells could result from elevated mitochondrial ROS
generation and disturbances of mitochondrial aerobic metabo-
lism. Interestingly, in obese Zucker rats and high fat-diet-
induced obese mice, the inhibition of FFA release from adipose
tissue and the inhibition of the rate-limiting enzyme in mito-
chondrial FFA oxidation reduces aortic ROS production and
prevents prostacyclin synthase and eNOS inactivation [6].
Because the activities of COX and CS and the expression
level of mitochondrial marker proteins remained unchanged, it
appears that the growth of EA.hy926 cells at high PAL concen-
trations did not change their maximal aerobic respiration capac-
ity or mitochondrial biogenesis. However, measurements of
mitochondrial function in isolated mitochondria indicate that
increased levels of PAL resulting from exposure to high PAL
concentrations do not only cause uncoupling but also impair
oxidative phosphorylation in endothelial mitochondria. Thus,
in addition to the findings from studies using animal models
and those on human subjects demonstrating the detrimental
effects of FFAs on vascular health [30], our study shows for
the first time that the chronic exposure of cultured endothelial
cells to high levels of FFAs leads to mitochondrial oxidative
dysfunction. The inhibition of mitochondrial respiration and the
decrease in ATP synthesis yield by excessive FFA levels could
be an important factor of endothelial lipotoxicity.
Our results indicate that, in response to high PAL concentra-
tions during endothelial cell growth, UCP2 activity and protein
levels are considerably increased in mitochondria. The increase
was less pronounced in mitochondria from the cells grown at a
higher PAL concentration (150 μM PAL), where the excess of
FFAs likely led to the impairment of the oxidative phosphory-
lation system, thereby decreasing the mΔΨ, which is the driv-
ing force of UCPs. We have shown previously that in endothe-
lial EA.hy926 cells, the high glucose-induced increase in the
activity of UCP2 reduces mitochondrial ROS formation and
improves cellular resistance to stress [13], although a greater
reduction in the yield of oxidative phosphorylation is observed
[14]. Thus, one physiological role of UCP2 could be the atten-
uation of mitochondrial ROS production under conditions of
oxidative stress, particularly given that endothelial mitochondria
are not particularly dependent on oxidative phosphorylation
[14]. UCPs are known to be upregulated in some mammalian
tissues when FFA availability exceeds mitochondrial oxidative
capacity [11]. Our results confirm previous implications that
UCP2 may serve as a sensor and a negative regulator of mito-
chondrial ROS production in endothelial cells with elevated
FFAs levels, protecting mitochondria from FFA-induced dam-
age. Beyond that, UCP2/3 have been suggested to take part in
the export of the fatty acid anions that can accumulate in the
mitochondrial matrix during mammalian cell overload [22] or
in the process of removing the lipid peroxides from the matrix
[9]. The knockdown of UCP2 in mice fed a high-fat diet has
been shown to cause a reduction in antioxidant capacity, endo-
thelial dysfunction, and atherosclerotic deterioration [18].
In conclusion, the growth of endothelial cells under high
PAL conditions induces numerous changes in their aerobic
metabolism (Fig. 7), particularly a shift toward the intensified
oxidation of FFAs. High levels of FFAs induce increased in-
tracellular and mitochondrial ROS production and therefore
excessive oxidative stress, which damages endothelial cells
and results in decreased cell viability. Observed differences
in mitochondrial ROS formation, mΔΨ, and expression of
mitochondrial antioxidant proteins, when comparing 100
and 150 μM PAL-treated cells, may be due to differences in
the PAL-induced cell death pathways (dominance of apoptosis
or necroptosis, respectively). However, further studies are
necessary to elucidate this phenomenon. Our results show also
that excess FFAs could result not only in elevated mitochon-
drial uncoupling, including UCP2-mediated uncoupling, but
also in impaired mitochondrial function. These observations
highlight the role of endothelial mitochondria in response to
metabolic disturbances related to high levels of FFAs.
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